LONDON, July 15 — The shift is subtle but significant: the two-month window the NHS gives itself to start cancer treatment may already be too long. A new study from Indiana University, published July 14, suggests that delays beyond 45 days increase the risk of metastasis by 55%. The finding lands at a moment when the NHS is already struggling to meet its own targets.
Current guidelines mandate that cancer patients in England begin treatment within two months of diagnosis. Yet the latest data shows only about 70% of patients actually hit that mark.
That shortfall matters more than ever. The study’s 45-day threshold is 15 days shorter than the current NHS standard. For every day past that point, the risk of the cancer spreading climbs.
Metastasis is what makes most cancers deadly.
The changing face of bowel cancer
The timing is especially urgent given a demographic shift already underway. Bowel cancer cases are rising in people under 50, with over 2,400 annual cases now recorded in the UK. This is not a disease that only affects older patients anymore.
The trend underneath is clear. A younger population is developing a cancer that the system was not designed to catch early in them.
When diagnosis comes later, the two-month treatment clock starts later too. Combine that with a target that only about 70% of patients meet, and the 45-day risk window becomes a real concern. The Indiana University research does not name a specific mechanism for why the 45-day mark is critical.
But the data is direct: delays past that point measurably worsen outcomes. For the NHS, which already misses its two-month target for nearly a third of patients, the implication is that even the patients who do get treated on time may be arriving too late.
What’s changing
The NHS has not yet responded to the study. Watch this space. The approximately 70% compliance figure is a political pressure point, and a study that questions the clinical basis of the target itself changes the conversation.
What’s changing is the benchmark. If 45 days becomes the new standard, the gap between current performance and acceptable care widens sharply.
The NHS would need to move faster than it currently does for everyone — and especially for the rising number of younger bowel cancer patients whose disease may be more aggressive by the time it is found. The study does not propose new guidelines. It presents the data.
But in a system already under strain, a 55% higher metastasis risk is not an abstract number. It is the kind of finding that forces a re-examination of how fast is fast enough.
The trend underneath is acceleration. Cancer is appearing earlier in life. The window for effective treatment is shorter than previously understood.
The NHS target is already missed by about a third of patients. Something has to give. Consult your doctor for medical advice.
Sources
{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “NHS cancer target missed: 70% treated in two months”, “description”: “LONDON, July 15 — The shift is subtle but significant: the two-month window the NHS gives itself to start cancer treatment may already be too…”, “datePublished”: “2026-07-15T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “Maria Romano”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.infopulsetoday.com/”}, “citation”: [{“@type”: “CreativeWork”, “url”: “https://en.wikipedia.org/wiki/National_Health_Service”}]}
